Peimisine (Ebeiensine) is a research compound with demonstrated bioactivity in models of asthma, acute lung injury, hepatic fibrosis, and hypertension. Its mechanisms include tracheal smooth muscle relaxation via M-receptor modulation and nitric oxide release, as well as protective effects against LPS-induced lung injury and angiotensin-converting enzyme inhibition.